Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Does Arch’s Rubin taking CFO role at Boundless signal IPO plans?

Former analyst arrived at venture firm in May after leaving EQRx

By Paul Bonanos, Director of Biopharma Intelligence
July 31, 2023 9:35 PM UTC

Longtime analyst and current VC Jami Rubin’s newest employer is Boundless Bio, an Arch portfolio company that could be exploring a public offering.

Boundless Bio Inc. introduced Rubin on Monday as its new CFO. The former Goldman Sachs and PJT Partners analyst had spent about two years at EQRx Inc. (NASDAQ:EQRX) before leaving this year; she joined Arch Venture Partners in May...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article